Free Trial

CME Group Inc. (NASDAQ:CME) Shares Sold by Achmea Investment Management B.V.

CME Group logo with Finance background

Achmea Investment Management B.V. cut its holdings in CME Group Inc. (NASDAQ:CME - Free Report) by 52.3% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 28,817 shares of the financial services provider's stock after selling 31,655 shares during the period. Achmea Investment Management B.V.'s holdings in CME Group were worth $7,645,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in the business. Alpine Bank Wealth Management bought a new position in CME Group during the 1st quarter valued at about $32,000. New Age Alpha Advisors LLC grew its holdings in CME Group by 50.0% during the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock valued at $30,000 after purchasing an additional 43 shares during the last quarter. Knuff & Co LLC bought a new position in CME Group during the 4th quarter valued at about $33,000. Banque Transatlantique SA bought a new position in CME Group during the 4th quarter valued at about $35,000. Finally, Whipplewood Advisors LLC bought a new position in CME Group during the 4th quarter valued at about $37,000. 87.75% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts recently commented on CME shares. UBS Group upped their price target on shares of CME Group from $290.00 to $305.00 and gave the company a "buy" rating in a report on Friday, April 25th. Erste Group Bank lowered shares of CME Group from a "strong-buy" rating to a "hold" rating in a research report on Saturday, May 24th. Barclays raised their target price on shares of CME Group from $279.00 to $283.00 and gave the stock an "equal weight" rating in a research report on Wednesday, April 23rd. Piper Sandler raised their target price on shares of CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a research report on Tuesday, April 8th. Finally, Bank of America raised their target price on shares of CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a research report on Wednesday, April 2nd. Three analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $258.20.

Check Out Our Latest Stock Report on CME Group

CME Group Stock Up 0.7%

CME stock traded up $1.93 during trading on Friday, hitting $274.76. 2,681,948 shares of the company's stock traded hands, compared to its average volume of 2,208,080. The firm has a market capitalization of $99.01 billion, a P/E ratio of 27.64, a PEG ratio of 3.73 and a beta of 0.45. The business has a fifty day simple moving average of $275.21 and a two-hundred day simple moving average of $256.68. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 1 year low of $193.17 and a 1 year high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.61 by $0.19. The company had revenue of $1.64 billion for the quarter, compared to analyst estimates of $1.56 billion. CME Group had a net margin of 57.71% and a return on equity of 14.03%. CME Group's revenue was up 10.4% compared to the same quarter last year. During the same period last year, the company posted $2.50 earnings per share. Sell-side analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th were issued a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.82%. The ex-dividend date of this dividend was Monday, June 9th. CME Group's dividend payout ratio is currently 50.30%.

Insiders Place Their Bets

In other news, Director Larry G. Gerdes sold 2,000 shares of the business's stock in a transaction on Thursday, April 24th. The shares were sold at an average price of $264.10, for a total transaction of $528,200.00. Following the sale, the director now directly owns 38,651 shares of the company's stock, valued at $10,207,729.10. The trade was a 4.92% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director William R. Shepard acquired 256 shares of the company's stock in a transaction dated Wednesday, June 25th. The shares were bought at an average cost of $270.53 per share, for a total transaction of $69,255.68. Following the completion of the acquisition, the director now directly owns 258,196 shares of the company's stock, valued at approximately $69,849,763.88. The trade was a 0.10% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders have sold 13,400 shares of company stock valued at $3,680,610. 0.30% of the stock is currently owned by insiders.

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Further Reading

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA: Another 200% Growth Ahead? (PLUS 2 Companies Riding Along)
3 Rising Stocks You’ll Want on Your Watchlist
Trillions in Defense Spending—3 Disruptive Stocks Set to Double

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines